ELOXX PHARMACEUTICALS, INC. (ELOX) Free cash flow 2016–2022
ELOXX PHARMACEUTICALS, INC. (ELOX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$31.9MFY2022 · since FY2016: -$8.9M → -$31.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$31.9M | +9.1% |
| FY2021 | -$35.1M | — |
| FY2019 | -$39.4M | -24.8% |
| FY2018 | -$31.6M | -95.4% |
| FY2017 | -$16.2M | -82.1% |
| FY2016 | -$8.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice